Updated: Sep 30, 2020
The American Hospital Association (AHA) has just released letters to five leading U.S drug companies. Turns out, these companies may have been taking action to limit distribution of certain 340B drugs to hospitals and health systems.
All in the midst of a global pandemic.
The AHA has prompted these companies to "cease this conduct immediately" and states "this has further demonstrated the fractured, inadequate state of the prescription drug supply chain."
Read up on this article here.
Are you a covered entity or FQHC struggling with 340B savings and programs? Allow our experts at Optimal340B to help. With our advanced technology, you'll get the highest possible savings curated exclusively for your company. Contact us today!